(0)

DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか？ or パスワードをお忘れですか？

Not a Member?

アカウントを作成して参加。

Virtual Event

2024年10月17日 (木) 午後 1:30 - 2024年10月17日 (木) 午後 5:30

(Central Europe Standard Time)

4051 Basel, Switzerland

EMA Clinical Trial Information System (CTIS) Information Day

Focus of this event will be on the follow up steps transitioned clinical trials and the revised transparency rules. From 31 January 2025 onwards, in only a few months time, the transition period is over and sponsors will need to comply with their obligations under the CTR and its Delegated Acts for all clinical trials conducted in the EU/EEA. On 18 June 2024, the revised transparency rules for the Clinical Trials Information System (CTIS) will become applicable, with the launch of a new version of the CTIS public portal.

戻る Agenda

Session 2 - Transparency in clinical trials

Session Chair(s)

Marianne Lunzer, DrMed

Marianne Lunzer, DrMed

Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care

AGES, Austria

Francesca Scotti

Francesca Scotti

CTIS Transparency Lead

European Medicines Agency, Netherlands

Transparency in Clinical Trials

Speaker(s)

Francesca Scotti

Overview of new transparency rules

Francesca Scotti

European Medicines Agency, Netherlands

CTIS Transparency Lead

Lora Killian, MBA

Lora Killian, MBA

Pfizer, United States

Clinical Trial Transparency and Disclosure Lead

Andrea Seidel-Glaetzer, MA, RN

New Transparency rules –How to manage from a non-commercial Sponsors’ Perspective

Andrea Seidel-Glaetzer, MA, RN

Coordination Centre For Clinical Trials Heidelberg (KKS), Germany

Head of Project Management

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。